Whitehawk Therapeutics (WHWK) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.83% |
| Dec 31, 2025 | -100.87% |
| Sep 30, 2025 | -43.46% |
| Jun 30, 2025 | -31.62% |
| Mar 31, 2025 | -46.21% |
| Dec 31, 2024 | -4.16% |
| Sep 30, 2024 | -7.61% |
| Jun 30, 2024 | -10.29% |
| Mar 31, 2024 | -10.57% |
| Dec 31, 2023 | -11.69% |
| Sep 30, 2023 | -11.64% |
| Jun 30, 2023 | -14.42% |
| Mar 31, 2023 | -61.49% |
| Dec 31, 2022 | -53.48% |
| Sep 30, 2022 | -49.05% |
| Jun 30, 2022 | -32.66% |
| Mar 31, 2022 | -29.83% |
| Dec 31, 2021 | -32.39% |
| Sep 30, 2021 | -161.95% |
| Jun 30, 2021 | -87.17% |
| Mar 31, 2021 | -101.97% |
| Dec 31, 2020 | -15.64% |
| Sep 30, 2020 | -496.33% |
| Jun 30, 2020 | -436.49% |
| Mar 31, 2020 | -330.88% |
| Dec 31, 2019 | -492.79% |
| Sep 30, 2019 | -375.40% |
| Jun 30, 2019 | -537.66% |
| Mar 31, 2019 | -518.91% |
| Dec 31, 2018 | -530.52% |
| Sep 30, 2018 | -482.11% |
| Jun 30, 2018 | -660.38% |
| Mar 31, 2018 | -451.17% |
| Dec 31, 2017 | -435.38% |
| Sep 30, 2017 | -440.55% |
| Jun 30, 2017 | -399.31% |
| Mar 31, 2017 | -331.23% |
| Dec 31, 2016 | 605.52% |
| Sep 30, 2016 | -192.32% |
| Jun 30, 2016 | -180.50% |
| Mar 31, 2016 | -116.09% |
| Dec 31, 2015 | 375.52% |
| Sep 30, 2015 | -22.71% |